A Phase II Study for p16+ Oropharyngeal Cancer PerSonalized De-escalation Treatment at University of MIchigan (CuSToMIze)

NCT05894083 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

150

Enrollment

OTHER

Sponsor class

Conditions

Oropharyngeal Cancer
Squamous Cell Carcinoma of the Oropharynx

Interventions

PROCEDURE: Surgery
COMBINATION_PRODUCT: Chemoradiation
OTHER: Observation
RADIATION: Post-operative radiation

Sponsor

University of Michigan Rogel Cancer Center